I've never been involved in an IPO so closely ever and we

New Post Public Reply Private Reply Replies (0) Message Board
ArryHere manfromjax #11666
449
I've never been involved in an IPO so closely ever and we are going through an IPO I believe, so hopefully this link will have our name soon.

https://www.nasdaq.com/markets/ipos/activity....b=upcoming

The one thing that excites me is that we can be priced higher based on our new valuation. Rory had mentioned that we have "firm commitment" from investors and I hope that is translates into "oversubcription" for us.

"If there are a lot of orders (oversubscribed), the company will price the shares higher."

I have a feeling that we will be a lot higher than $7-10 by the time we uplist to NASDAQ but we will all see how it goes.

Here's a good read:

What Is an IPO (Initial Public Offering)?
An Initial Public Offering (IPO) is the first sale of stocks issued by a company to the public.

Initial Public Offering (IPO)

Companies that are looking to grow often use an Initial Public Offering to raise capital. The biggest advantage of an IPO is the additional capital raised. The capital raised can be used to buy additional property, plant and equipment (PPE), fund research and development (R&D), expand, or pay off existing debt. There is also an increased awareness of a company through an IPO, which typically generates a wave of potential new customers.

In addition, private investors/founding partners/venture capitalists can use an IPO as an exit strategy. For example, when Facebook went public, Mark Zuckerberg sold nearly 31 million shares worth US$1.1 billion. A public offering is one of the most common ways venture capitalists make a significant amount of money.

Steps in an Initial Public Offering (IPO)
The first step in an Initial Public Offering is to hire an investment bank, or banks, to handle the IPO. Investment banks can either work together, with one taking the lead, or work alone.

Next, everyone involved in the IPO – the management team, auditors, accountants, the underwriting banks, lawyers, and Securities and Exchange Commission (SEC) experts – attend a meeting to discuss the offering and determine the timing of the filing. Similar meetings happen throughout the entire underwriting process.

After the meeting, due diligence is required to be conducted on the company to make sure the registration statements are accurate. Tasks include market due diligence, legal and IP due diligence, financial and tax due diligence.

The end result of the due diligence is the S-1 Registration Statement. The information in the statement includes historical financial statements, key data, company overview, risk factors, and more.

A pre-IPO analyst meeting is held after the S-1 Registration Statement is filed to educate bankers and analysts about the company. Bankers and analysts are also briefed on how to sell the company to investors. A preliminary prospectus can also be drafted.

Pre-marketing is conducted to determine whether institutional investors like the sector and the company, and the price they would pay per share. In conjunction with the internal valuation, a price range for the offering is set by the banks. The S-1 Registration Statement is amended with the price range.

After the pre-marketing work and S-1 Registration Statement is completed, the management team travels around the world to meet with investors and market the company. This is a very important process as orders for the number of shares by investors and the price they are willing to pay are determined. The price range may be further revised.

The management team will meet with the investment banks to decide on the final price of the deal based on the orders. If there are a lot of orders (oversubscribed), the company will price the shares higher.

Once the IPO is priced, the investment banks will allocate shares to investors and the stock will start trading in the primary market for the public to buy and sell.

TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Cheers!!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hims & Hers Health Faces Revenue Challenges and Legal Issues

Updated Category News Views 246

Hims & Hers Revenue Challenges Amid Stock Decline In recent trading sessions, Hims & Hers Health reported notable stock fluctuations as the company unveiled a decline in revenue per customer linked to its customization of GLP-1 medications for weight loss. This announcement caused an almost 11% drop in the stock price. Impacts of Collaboration Termination This steep...

Continue Reading
Entrée Resources Reports Solid Results for Q3 2025

Updated Category News Views 166

Entrée Resources Ltd. Overview Entrée Resources Ltd. (TSX: ETG; OTCQB: ERLFF), a reputable Canadian mining company focused on the Oyu Tolgoi project, has announced its interim financial results for the third quarter of 2025. This announcement sheds light on its ongoing operations and future plans, emphasizing the company's significant role in one of the world's largest...

Continue Reading
Bucket List Wine Dinners Beckon to Los Angeles

Updated Category News Views 10

Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...

Continue Reading
BioLife Solutions Enhances Growth Potential with $73 Million Sale

Updated Category News Views 68

BioLife Solutions Announces $73 Million Sale of SciSafe In a significant move aimed at reinforcing its strategic direction, BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the development and supply of cell processing tools and services for the cell and gene therapy market, has announced the sale of its biostorage subsidiary, SciSafe Holdings, Inc. The...

Continue Reading
Advancements in Universal Vaccine Development by Dx&Vx

Updated Category News Views 154

Innovative Pathway Towards a Universal COVID-19 Vaccine In the wake of a global resurgence of COVID-19, Dx&Vx (DXVX) is stepping up its efforts to develop a universal vaccine aimed at providing protection against all variants of the virus. With the recent acquisition of cutting-edge technology, this next-generation vaccine is set to attract significant global interest....

Continue Reading